Gaba(b) agonists for the treatment of ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Gaba(b) agonists for the treatment of alcohol use disorder
Auteur(s) :
Mirijello, A. [Auteur]
Caputo, Fabio [Auteur]
Vassallo, G. [Auteur]
Rolland, Benjamin [Auteur]
Tarli, C. [Auteur]
Gasbarrini, A. [Auteur]
Addolorato, Giovanni [Auteur]
Caputo, Fabio [Auteur]
Vassallo, G. [Auteur]
Rolland, Benjamin [Auteur]
Tarli, C. [Auteur]
Gasbarrini, A. [Auteur]
Addolorato, Giovanni [Auteur]
Titre de la revue :
Current Pharmaceutical Design
Nom court de la revue :
Curr. Pharm. Design
Numéro :
21
Pagination :
3367-3372
Date de publication :
2015-01-01
ISSN :
1381-6128
Mot(s)-clé(s) en anglais :
craving
pharmacological treatment
GABA(B) agonists
Alcohol use disorder
pharmacological treatment
GABA(B) agonists
Alcohol use disorder
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Almost 10% of the world's population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected ...
Lire la suite >Almost 10% of the world's population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected by AUD. Among effective drugs useful in the treatment of AUD, GABAB-ergic medications have been tested with encouraging results (i.e. sodium oxybate, baclofen, gabapentin, pregabalin and tiagabine). The present review will summarize available data on these medications.Lire moins >
Lire la suite >Almost 10% of the world's population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected by AUD. Among effective drugs useful in the treatment of AUD, GABAB-ergic medications have been tested with encouraging results (i.e. sodium oxybate, baclofen, gabapentin, pregabalin and tiagabine). The present review will summarize available data on these medications.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Troubles cognitifs dégénératifs et vasculaires
Date de dépôt :
2019-11-27T13:04:39Z